SEOUL, South Korea, March 22, 2023 /PRNewswire/ -- PRAZEN (CEO/Heekyung Kim), a Korean startup specialized in optics for augmented reality (AR) products will present unique new AR glasses and an AR projector at AWE 2023 (May 31 -June 2, Santa Clara, California, USA). The AR glasses of Prazen has a peculiar optical layout of "Direct Projection", unlike the other previously announced AR glasses. PRAZEN's AR optical module shows much higher light efficiency since it projects lights from micro …

HAYWARD, Calif., March 22, 2023 /PRNewswire/ -- Avirmax CMC Inc. (ACI), a cGMP-licensed CDMO, is announcing the implementation of its newly-developed Sf rhabdovirus-free cell lines (under the generic trademark of Sf-RVF™) developed for producing recombinant adeno-associated viral vectors (rAAV). Avirmax CMC Inc. Delivers rAAV Products with Higher Viral Safety Assurance Using Sf-RVF™ Cell Lines

TOKYO, March 22, 2023 /PRNewswire/ -- Nissan Motor Co., Ltd. announced today a prototype sedan equipped with approximately 30 devices born from free ideas and ingenuity. The Contemporary Lifestyle Vehicle, created through a bricolage approach, is to be on display at the Nissan Global Headquarters Gallery here from March 24 to April 2 and also viewable on Nissan's YouTube channel starting today. The prototype is based on the iconic Skyline and packed …

BEIJING, March 22, 2023 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888) ("Baidu" or the "Company"), a leading AI company with strong Internet foundation, today announced it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022 with the Securities and Exchange Commission on March 22, 2023 (the "Form 20-F"). The annual report can be accessed on the Company's investor relations website at . The Company will provide a hard copy of its …

BELOIT, Wis. and BRAINTREE, Mass., March 22, 2023 /PRNewswire/ -- Regal Rexnord Corporation (NYSE: RRX) ("Regal Rexnord") and Altra Industrial Motion Corp. (Nasdaq: AIMC) ("Altra") jointly announced today that they have received all required regulatory approvals to complete the previously announced acquisition of all of the issued and outstanding shares of common stock of Altra, whereby a wholly owned subsidiary of Regal Rexnord will be merged with and into Altra, with Altra surviving the merger …

TSX and OTCQX: MPVD TORONTO and NEW YORK, March 22, 2023 /PRNewswire/ - Mountain Province Diamonds Inc. ("Mountain Province", or the "Company") (TSX: MPVD) (OTCQX: MPVD) today announces its financial and operating results for the fourth quarter ("the Quarter" or "Q4 2022") and the full year ended December 31, 2022 ("FY 2022"). All figures are expressed in Canadian dollars unless otherwise noted and are unaudited. FY 2022 Highlights Adjusted EBITDA1 of $177.2 million, up 31% …

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of RAPT Therapeutics, Inc. ("RAPT" or the "Company") (NASDAQ: RAPT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether RAPT and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, March 22, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the common stock of Fidelity National Information Services, Inc. (NYSE: FIS) between February 9, 2021 and February 10, 2023, both dates inclusive (the "Class Period"), of the important May 5, 2023 lead plaintiff deadline. SO WHAT: If you purchased Fidelity National securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ZTO Express (Cayman) Inc. ("ZTO" or the "Company") (NYSE: ZTO).  Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether ZTO and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Marathon Digital Holdings, Inc. ("Marathon" or the "Company") (NASDAQ: MARA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Marathon and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, March 22, 2023POMERANTZ /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Fulcrum and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

SACRAMENTO, Calif., March 22, 2023 /PRNewswire/ -- SBx1 2, the newly amended proposal for a price gouging penalty and oil refiner transparency, passed its first test in the California Senate Utilities, Energy and Communications Committee by a vote of 12 to 2 today. "Senate Democrats have rightly answered Governor Newsom's call to give the state the power to levy a penalty on price gouging and bring California's gasoline prices back in line with the rest of the nation's," said Jamie Court, president of Consumer Watchdog. "The Democrats understand the oil refiners will only get in line when they face sticks, not just carrots, and SBx1 2 puts a big stick in the hands of regulators. The bill also allows for market surveillance through new transparency measures and a bureau dedicated to watchdogging against market manipulation. This is a smart proposal that answers a decade old problem we call The Golden State Gouge."

Huma's platform is ready to use, reducing the time and cost for other companies to bring regulated SaMD products to market, democratising digital health innovation across the industryClass IIb certification expands the patient population and level of disease severity that can be managed; allowing delivery of personalised care through the use of predictive algorithmsClinical evidence from over 20 peer-reviewed publications and studies were submitted for regulatory assessment of clinical safety …

SUZHOU, China, March 22, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces the successful dosing of first patient in the U.S. Phase I Study of TST003 (NCT05731271), its first-in-class, high affinity humanized monoclonal antibody targeting Gremlin1, for the treatment of solid tumors. …

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nutanix, Inc. ("Nutanix" or the "Company") (NASDAQ: NTNX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Nutanix and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

SUZHOU, China, March 22, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announces that two preclinical studies in relation to TST003, a First-in-Class mAb Targeting GREMLIN-1, and TST010, an ADCC enhanced anti-CD25 mAb will be presented as posters at the American Association for Cancer Research …

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DISH Network Corporation ("DISH" or the "Company") (NASDAQ: DISH). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether DISH and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Funko, Inc. ("Funko" or the "Company") (NASDAQ:  FNKO).  Such investors are advised to contact Robert S. Willoughby at  newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Funko and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of First Republic Bank ("First Republic" or the "Company") (NYSE: FRC). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether First Republic and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, March 22, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Techtronic Industries Company Limited ("Techtronic" or the "Company") (OTCMKTS: TTNDY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The investigation concerns whether Techtronic and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.